Your browser doesn't support javascript.
loading
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck, Lisa A; Thaçi, Diamant; Deleuran, Mette; Blauvelt, Andrew; Bissonnette, Robert; de Bruin-Weller, Marjolein; Hide, Michihiro; Sher, Lawrence; Hussain, Iftikhar; Chen, Zhen; Khokhar, Faisal A; Beazley, Bethany; Ruddy, Marcella; Patel, Naimish; Graham, Neil M H; Ardeleanu, Marius; Shumel, Brad.
Afiliación
  • Beck LA; Department of Dermatology, University of Rochester Medical Center, Rochester, NY, USA.
  • Thaçi D; University of Lübeck, Lübeck, Germany.
  • Deleuran M; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Blauvelt A; Oregon Medical Research, Portland, OR, USA.
  • Bissonnette R; Innovaderm Research, Montreal, QC, Canada.
  • de Bruin-Weller M; National Expertise Center of Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hide M; Department of Dermatology, Hiroshima University, Hiroshima, Japan.
  • Sher L; Peninsula Research Associates, Rolling Hills Estates, CA, USA.
  • Hussain I; Vital Prospects Clinical Research Institute, PC, Tulsa, OK, USA.
  • Chen Z; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.
  • Khokhar FA; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.
  • Beazley B; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.
  • Ruddy M; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.
  • Patel N; Sanofi, Bridgewater, NJ, USA.
  • Graham NMH; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.
  • Ardeleanu M; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.
  • Shumel B; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA. brad.shumel@regeneron.com.
Am J Clin Dermatol ; 21(4): 567-577, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32557382
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Clin Dermatol Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Clin Dermatol Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda